|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States. |
| 公司地址
| One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933 |
| 電話號碼
| +1 732 524-0400 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.jnj.com |
| 員工數量
| 138200 |
| Ms. Elizabeth Forminard |
Executive Vice President and Chief Legal Officer |
-- |
11/02/2026 |
| Ms. Kristen Mulholland |
Executive Vice President and Chief Human Resources Officer |
-- |
11/02/2026 |
| Mr. Timothy Schmid |
Executive Vice President and Worldwide Chairman, MedTech |
美元 896.31K |
11/02/2026 |
| Mr. Joaquin Duato |
Chairman of the Board and Chief Executive Officer |
美元 1.60M |
11/02/2026 |
| Mr. Joseph J. Wolk, C.P.A. |
Executive Vice President and Chief Financial Officer |
美元 1.21M |
11/02/2026 |
| Mr. James D. Swanson |
Executive Vice President and Chief Information Officer |
-- |
11/02/2026 |
| Ms. Jennifer L. Taubert |
Executive Vice President and Worldwide Chairman, Innovative Medicine |
美元 1.19M |
11/02/2026 |
| Ms. Kathryn E. Wengel |
Executive Vice President and Chief Technical Operations and Risk Officer |
-- |
11/02/2026 |
| Mr. Robert J. Decker, Jr |
Controller and Chief Accounting Officer |
-- |
11/02/2026 |
| Dr. John C. Reed,M.D.,PhD |
Executive Vice President, Innovative Medicine, R&D |
美元 1.19M |
11/02/2026 |
| Ms. Vanessa Broadhurst |
Executive Vice President, Global Corporate Affairs |
-- |
11/02/2026 |
|
|
| Dr. Paula A. Johnson,M.D. |
Independent Director |
11/02/2026 |
| Ms. Marillyn A. Hewson |
Lead Independent Director |
11/02/2026 |
| Mr. Hubert Joly |
Independent Director |
11/02/2026 |
| Mr. Eugene A. Woods |
Independent Director |
11/02/2026 |
| Dr. Mary C. Beckerle, PhD |
Independent Director |
11/02/2026 |
| Dr. Mark B. McClellan, M.D.,PhD |
Independent Director |
11/02/2026 |
| Mr. Daniel Eduardo Pinto |
Director |
11/02/2026 |
| Mr. Joaquin Duato |
Chairman of the Board and Chief Executive Officer |
11/02/2026 |
| Dr. Jennifer A. Doudna, PhD |
Independent Director |
11/02/2026 |
| Dr. Nadja Y. West, M.D. |
Independent Director |
11/02/2026 |
| Mr. Mark A. Weinberger |
Independent Director |
11/02/2026 |
| Mr. John G. Morikis |
Director |
11/02/2026 |
|
|
|
|
